38454193|t|BDNF Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer's disease.
38454193|a|OBJECTIVE: Allelic variation in the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism has been shown to moderate rates of cognitive decline in preclinical sporadic Alzheimer's disease (AD; i.e., Abeta + older adults), and pre-symptomatic autosomal dominant Alzheimer's disease (ADAD). In ADAD, Met66 was also associated with greater increases in CSF levels of total-tau (t-tau) and phosphorylated tau (p-tau181). This study sought to determine the extent to which BDNF Val66Met is associated with changes in episodic memory and CSF t-tau and p-tau181 in Abeta + older adults in early-stage sporadic AD. METHOD: Abeta + Met66 carriers (n = 94) and Val66 homozygotes (n = 192) enrolled in the Alzheimer's Disease Neuroimaging Initiative who did not meet criteria for AD dementia, and with at least one follow-up neuropsychological and CSF assessment, were included. A series of linear mixed models were conducted to investigate changes in each outcome over an average of 2.8 years, covarying for CSF Abeta42, APOE epsilon4 status, sex, age, baseline diagnosis, and years of education. RESULTS: Abeta + Met66 carriers demonstrated significantly faster memory decline (d = 0.33) and significantly greater increases in CSF t-tau (d = 0.30) and p-tau181 (d = 0.29) compared to Val66 homozygotes, despite showing equivalent changes in CSF Abeta42. CONCLUSIONS: These findings suggest that reduced neurotrophic support, which is associated with Met66 carriage, may increase vulnerability to Abeta-related tau hyperphosphorylation, neuronal dysfunction, and cognitive decline even prior to the emergence of dementia. Additionally, these findings highlight the need for neuropsychological and clinicopathological models of AD to account for neurotrophic factors and the genes which moderate their expression.
38454193	0	4	BDNF	Gene	627
38454193	5	13	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
38454193	24	47	episodic memory decline	Disease	MESH:D060825
38454193	52	55	tau	Gene	4137
38454193	94	113	Alzheimer's disease	Disease	MESH:D000544
38454193	151	184	brain-derived neurotrophic factor	Gene	627
38454193	186	190	BDNF	Gene	627
38454193	192	200	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
38454193	250	267	cognitive decline	Disease	MESH:D003072
38454193	292	311	Alzheimer's disease	Disease	MESH:D000544
38454193	313	315	AD	Disease	MESH:D000544
38454193	323	328	Abeta	Gene	351
38454193	385	404	Alzheimer's disease	Disease	MESH:D000544
38454193	406	410	ADAD	Disease	MESH:D000544
38454193	416	420	ADAD	Disease	MESH:D000544
38454193	422	427	Met66	ProteinMutation	tmVar:p|Allele|M|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	494	497	tau	Gene	4137
38454193	501	504	tau	Gene	4137
38454193	525	528	tau	Gene	4137
38454193	592	596	BDNF	Gene	627
38454193	597	605	Val66Met	ProteinMutation	tmVar:p|SUB|V|66|M;HGVS:p.V66M;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606;CA#:127325
38454193	662	665	tau	Gene	4137
38454193	682	687	Abeta	Gene	351
38454193	727	729	AD	Disease	MESH:D000544
38454193	739	744	Abeta	Gene	351
38454193	747	752	Met66	ProteinMutation	tmVar:p|Allele|M|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	775	780	Val66	ProteinMutation	tmVar:p|Allele|V|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	819	838	Alzheimer's Disease	Disease	MESH:D000544
38454193	893	904	AD dementia	Disease	MESH:D000544
38454193	1126	1133	Abeta42	Gene	351
38454193	1135	1139	APOE	Gene	348
38454193	1220	1225	Abeta	Gene	351
38454193	1228	1233	Met66	ProteinMutation	tmVar:p|Allele|M|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	1277	1291	memory decline	Disease	MESH:D060825
38454193	1347	1351	-tau	Gene	4137
38454193	1399	1404	Val66	ProteinMutation	tmVar:p|Allele|V|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	1460	1467	Abeta42	Gene	351
38454193	1565	1570	Met66	ProteinMutation	tmVar:p|Allele|M|66;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
38454193	1611	1616	Abeta	Gene	351
38454193	1625	1628	tau	Gene	4137
38454193	1651	1671	neuronal dysfunction	Disease	MESH:D009461
38454193	1677	1694	cognitive decline	Disease	MESH:D003072
38454193	1726	1734	dementia	Disease	MESH:D003704
38454193	1841	1843	AD	Disease	MESH:D000544
38454193	Association	MESH:D000544	4137
38454193	Association	MESH:D003704	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
38454193	Association	MESH:D003072	627
38454193	Association	MESH:D000544	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
38454193	Association	MESH:D003072	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
38454193	Association	MESH:D060825	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
38454193	Association	351	4137
38454193	Association	MESH:D009461	RS#:6265;HGVS:p.V66M;CorrespondingGene:627
38454193	Association	MESH:D060825	351
38454193	Association	MESH:D000544	627
38454193	Association	MESH:D003704	RS#:6265;CorrespondingGene:627
38454193	Positive_Correlation	MESH:D003072	RS#:6265;CorrespondingGene:627
38454193	Association	MESH:D060825	627
38454193	Association	MESH:D003072	351
38454193	Association	MESH:D060825	RS#:6265;CorrespondingGene:627
38454193	Association	4137	627
38454193	Association	MESH:D009461	RS#:6265;CorrespondingGene:627
38454193	Association	MESH:D003072	4137
38454193	Association	MESH:D009461	351
38454193	Association	MESH:D003704	627
38454193	Association	MESH:D009461	627

